GlytecGlytec announced today that it introduced the latest version of its eGlycemic Management System (eGMS) for managing insulin.

Waltham, Mass.-based Glytec’s eGMS is centered around the FDA-cleared Glucommander algorithm, which leverages real-time and historical data to recommend insulin dosing by learning each patient’s insulin sensitivity and anticipating future needs, leading to a personalized treatment regime that can reduce hypoglycemia, hyperglycemia, lengths of stay, readmissions and cost of care, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.